Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) TFAP2B Antibodies:
anti-Rat (Rattus) TFAP2B Antibodies:
anti-Human TFAP2B Antibodies:
Go to our pre-filtered search.
Human Polyclonal TFAP2B Primary Antibody for ELISA, WB - ABIN563152
Bassett, Pontoriero, Feng, Marquardt, Fini, Williams, West-Mays: Conditional deletion of activating protein 2alpha (AP-2alpha) in the developing retina demonstrates non-cell-autonomous roles for AP-2alpha in optic cup development. in Molecular and cellular biology 2007
AP-2beta up-regulates the transcription of the CRYAB (show CRYAB Antibodies) gene through stabilizing p53 (show TUBB Antibodies).
CVAK104 (show SCYL2 Antibodies) binds ATP and functions in vitro as a poly-L-lysine-stimulated kinase that is capable of autophosphorylation and phosphorylating the beta2-adaptin (show AP2B1 Antibodies) subunit of AP2 (show TFAP2A Antibodies)
tfap2b and its close relative, tfap2a (show TFAP2A Antibodies), play redundant roles in the ectoderm to control skeletogenesis of neural crest cells
Study systematically examined the expression profile of AP-2 (show TFAP2A Antibodies) family in the developing mouse and chick spinal cord and found that AP-2alpha (show TFAP2A Antibodies) and AP-2beta are specifically expressed in post-mitotic dorsal interneurons. Subsequent functional assessment in chick embryos demonstrated that AP-2alpha (show TFAP2A Antibodies) and AP-2beta have distinct functions in dorsal interneuron specification and differentiation.
AP-2 beta and beta-catenin (show CTNNB1 Antibodies) interact both in vitro through GST pull-down assays and in vivo by co-immunoprecipitation. We further identified the interaction regions to the DNA-binding domain of AP-2 beta and the 1-9 Armadillo (show PKP1 Antibodies) repeats of beta-catenin (show CTNNB1 Antibodies).
the Tfap2a (show TFAP2A Antibodies) and Tfap2b transcription factors were identified as two major downstream effectors of Ptf1a (show PTF1A Antibodies).
critical roles for AP-2 (show TFAP2A Antibodies) activity in retinogenesis, delineating the overlapping expression patterns of Tcfap2a (show TFAP2A Antibodies), Tcfap2b, and Tcfap2c in the neural retina, and revealing a redundant requirement for Tcfap2a (show TFAP2A Antibodies) and Tcfap2b in horizontal and amacrine cell development
Tfap2b is associated with the development and remodeling of mouse ductus arteriosus and limb patterning.
PKD (show PRKD1 Antibodies) is thus a common modulator of the DNA binding activity of AP-2alpha (show TFAP2A Antibodies) and AP-2beta through their phosphorylation for negative regulation of the ABCA1 (show ABCA1 Antibodies) and adiponectin (show ADIPOQ Antibodies) genes expression, respectively.
postprandial activation of PKCmicro plays a role in disordered postprandial adipocytokine expression through AP-2beta.
Whereas AP-2alpha (show TFAP2A Antibodies)/beta transcription factors are in vivo not required for the onset or maintenance of noradrenergic differentiation, their essential survival functions are demonstrated for sympathetic progenitors and noradrenergic neurons.
Data suggest that AP-2beta plays critical roles in the epinephrine phenotype and maturation of adrenal chromaffin cells.
Tfap2beta, Et-1 (show EDN1 Antibodies), and Hif2alpha (show EPAS1 Antibodies) act in a transcriptional network during ductal smooth muscle development. Disruption of this pathway may contribute to patent ductus arteriosus by affecting development of smooth muscle in the ductus arteriosus.
AP-2 beta and beta-catenin (show CTNNB1 Antibodies) interact both in vitro through GST (show SLCO6A1 Antibodies) pull-down assays and in vivo by co-immunoprecipitation. We further identified the interaction regions to the DNA-binding domain of AP-2 beta and the 1-9 Armadillo (show PKP1 Antibodies) repeats of beta-catenin (show CTNNB1 Antibodies).
Single nucleotide polymorphisms (SNP) in angiotensin II receptor, type 1 (AGTR1 (show AGTR1 Antibodies)), transcription factor AP-2 beta (TFAP2B), and tumor necrosis factor (show TNF Antibodies) receptor-associated factor 1 (TRAF1 (show TRAF1 Antibodies)) have been reported to be associated with the incidence of PDA in preterm infants.
results suggest that TFAP2B is playing a vital role in retaining retinoic acid responsiveness and mediating noradrenergic neuronal differentiation in neuroblastoma (show ARHGEF16 Antibodies).
TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK (show EPHB2 Antibodies) and VEGF (show VEGFA Antibodies)/PEDF (show SERPINF1 Antibodies) signaling.
The AP-2beta polymorphism significantly influenced cognitive performance, whereas the MAOA (show MAOA Antibodies) and COMT (show COMT Antibodies) polymorphisms did not.
A haploinsufficiency effect of TFAP2B could be involved in familial isolated patent ductus arteriosus.
TFAP2B rs987237 and dietary protein/carbohydrate interacted to modify weight maintenance.
genomic GATA4 (show GATA4 Antibodies) and TFAP2B missense mutations may be associated with nonfamilial congenital heart disease with diverse clinical phenotypes in patients with congenital heart disease from southern China
Under energy restriction, TFAP2B may modify the effect of dietary fat intake on weight loss and waist reduction
The findings suggest the lack of involvement of known mutations of TFAP2B with syndromic or nonsyndromic CHDs in Mysore patients
Expression of TFAP2beta and TFAP2gamma (show TFAP2C Antibodies) genes in Xenopus laevis.
LH and insulin (show INS Antibodies) stimulate transcription of -976/+31 bp 5 (show HSPD1 Antibodies)'-upstream cis (show CISH Antibodies)-acting region of porcine CYP17 (show CYP17A1 Antibodies) gene. Maximal transcriptional responsiveness requires proximal Sp1 (show SP1 Antibodies) and AP-2-like (show TFAP2D Antibodies) sequences -193 to -180 bp 5 (show HSPD1 Antibodies)' upstream of transcriptional start site.
Data demonstrates the colocalization of MARK with AP-2 and clathrin, as well as other MARK-interacting proteins such as PAK5.
This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives.
, beta adaptin drosophila 1
, transcription factor AP-2 beta
, AP2 transcription factor
, activating enhancer-binding protein 2 beta
, transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
, transcription factor AP-2-beta
, activating enhancer-binding protein 2-beta
, activating enhancer binding protein 2 beta